Find your PDFs fast.
Welcome to the Pubget Medical Subject Headings (MESH) browser. Click on a topic or subtopic below to explore related papers. In the gold box is the most recent paper about the current MESH term, and below are 20 related papers.
Interleukin-5 (0):
Recent article
Interleukin-5
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
| < More recent | Older article > |
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Transfusion (50)2 2010
Abstract
Invariant natural killer T cells (iNKT cells) may suppress graft-versus-host disease (GVHD) after allogeneic transplantation. The purpose of this study was to investigate the therapeutic potential of iNKT cells from major histocompatibility complex (MHC)-mismatched donors for prevent...
|
PMID: 19788510
PDF is available here.
PDF is available here.
Abstract
We have determined whether highly preterm infants (<31 weeks) are able to mount these immune responses during vaccination. Forty-eight premature infants were vaccinated at 2, 3, and 4 months of their chronological age with an acellular (Pa; n = 24) or a whole-cell (Pw; n = 24) tetravalent diphtheria...
|
PMID: 20016042
PDF is available here.
PDF is available here.